Infections caused by carbapenem-resistant gram-negative pathogens in hospitalized children

Pediatric Infectious Disease Journal

Volumn 32, Issue 4, 2013, Pages

  Maltezou, Helena C ^a   Kontopidou, Flora ^a   Katerelos, Panos ^a   Daikos, George ^a   Roilides, Emmanuel ^b   Theodoridou, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Carbapenem resistant; Children; Gram negative; Hospital; Nosocomial; Pediatric

Indexed keywords

CARBAPENEM; COLISTIN; GENTAMICIN; TIGECYCLINE;

ACINETOBACTER; ACINETOBACTER INFECTION; ADOLESCENT; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; KLEBSIELLA INFECTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; PSEUDOMONAS INFECTION; SCHOOL CHILD; SURGICAL INFECTION; URINARY TRACT INFECTION;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; SURVIVAL ANALYSIS;

EID: 84876280882     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182804b49     Document Type: Article

References (26)

1. Maltezou HC. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance? Int J Antimicrob Agents. 2009;33:4-05.e-405.e7.
2. Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682-707.
3. Ambler RE The structure of beta-lactamases. Philos Trans R Soc Lond B BiolSci. 1980;289:321-331.
4. Overturf GD. Carbapenemases: a brief review for pediatric infectious disease specialists. Pediatr Infect Dis J. 2010;29:68-70.
5. Landman D, Bratu S, Kochar S, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother. 2007;60:78-82.
6. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602.
7. Maltezou HC, Giakkoupi P, Maragos A, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect. 2009;58:213-219.
8. Daikos GL, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53:1868-1873.
9. Schwaber MJ, Lev B, Israeli A, et al.; Israel Carbapenem-Resistant Enterobacteriaceae Working Group. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011;52:848-855.
10. Glupczynski Y, Huang TD, Bouchahrouf W, et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents. 2012;39:168-172.
11. Perez F, Endimiani A, Ray AJ, et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother. 2010;65:1807-1818.
12. Dong F, Xu XW, Song WQ, et al. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from apaediatric clinic in China. Chin Med J. 2008;121:1611-1616.
13. Birgy A, Doit C, Mariani-Kurkdjian P, et al. Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol. 2011;49:3085-3087.
14. Oteo J, Hernandez-Almaraz JL, Gil-Antón J, et al. Outbreak of vim-1-car-bapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J. 2010;29:1144-1146.
15. Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012;55:852-859.
16. European Centre for Disease Prevention and Control. European Antimicrobial Resistance Surveillance System Annual Reports. Available at: http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/publications/Pages/ documents.aspx. Accessed October 18, 2012.
17. WHONET Greece (Greek Network for the Antimicrobial Resistance Surveillance), Cumulative Results July-December 2010. Available at: http://www.mednet.gr/whonet/top.htm. Accessed October 18, 2012.
18. Hellenic Center for Disease Control and Prevention. Action Plan to Combat Infections due to Multi-Drug Resistant, Gram-Negative Pathogens in Hospitals in Greece. Available at: http://www.keelpno.gr/Portals/0/ %CE%91%CF%81%CF%87%CE%B5%CE%AF%CE%B1/ %CE%A0%CE%BF%CE%BB%CF%85%CE%B1%CE%BD%CE%B8%CE%B5%CE%BA%CF%84%CE%B9%CE%BA%CE%AC% 20%CE%A0%CE%B1%CE%B8%CE%BF%CE%B3%CF%8C%CE%BD%CE%Bl/prokroustis%20final-l.doc. Accessed October 18, 2012.
19. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
20. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement (June 2010 Update) M100-S20-U Wayne, PA: Clinical Laboratory Standards Institute; 2010.
21. Sheng WH, Liao CH, Lauderdale TL, et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis. 2010;14: e764-e769.
22. Landman D, Babu E, Shah N, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother. 2012;67:1427-1431.
23. Zagorianou A, Sianou E, Iosifidis E, et al. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill. 2012;17:20088.
24. Viau RA, Hujer AM, Marshall SH, et al. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a longterm care facility for children and young adults in Northeast Ohio. Clin Infect Dis. 2012;54:1314-1321.
25. Marchaim D, Chopra T, Perez F, et al. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol. 2011;32:861-871.
26. Wisplinghoff H, Seifert H, Tallent SM, et al. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J. 2003;22:686-691.